TARGETING A BROMODOMAIN PROTEIN, CECR2, IN BREAST CANCER

$1,674,999FY2021Defense Health AgencyDOD

Yale Univ

Investigators

View source on USAspending →

TARGETING A BROMODOMAIN PROTEIN, CECR2, IN BREAST CANCER · GrantIndex